Cresco Labs Inc (CRLBF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 108,520 | 113,016 | 74,811 | 90,452 | 121,510 |
Receivables | 52,491 | 58,559 | 59,099 | 50,060 | 56,939 |
Inventories | 107,789 | 114,641 | 120,861 | 134,881 | 134,608 |
Other current assets | 2,870 | 10,245 | 2,862 | 3,213 | 3,569 |
TOTAL | $278,087 | $303,167 | $265,244 | $286,320 | $326,046 |
Non-Current Assets | |||||
PPE Net | 368,308 | 382,783 | 388,276 | 390,583 | 379,722 |
Investments And Advances | 730 | 806 | 931 | 1,191 | 1,228 |
Intangibles | 576,663 | 577,705 | 712,850 | 736,650 | 738,145 |
Other Non-Current Assets | 134,679 | 134,692 | 143,930 | 135,813 | 138,551 |
TOTAL | $1,080,380 | $1,095,986 | $1,245,987 | $1,264,237 | $1,257,646 |
Total Assets | $1,358,467 | $1,399,153 | $1,511,231 | $1,550,557 | $1,583,692 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | 11,817 | 27,783 | 18,293 | 28,112 | 10,976 |
Accounts payable and accrued liabilities | 27,587 | 19,626 | 20,393 | 20,134 | 28,093 |
Accrued Expenses | 69,079 | 76,494 | 78,032 | 76,499 | 65,161 |
TOTAL | $200,242 | $260,882 | $237,646 | $272,549 | $255,865 |
Non-Current Liabilities | |||||
Long Term Debt | 497,713 | 490,501 | 471,553 | 470,895 | 476,891 |
Deferred Revenues | N/A | 13 | 2,108 | 41,046 | 47,834 |
Other Non-Current Liabilities | 19,367 | 19,022 | 30,339 | 8,761 | 26,286 |
TOTAL | $730,158 | $712,409 | $726,605 | $710,633 | $740,144 |
Total Liabilities | $930,400 | $973,291 | $964,251 | $983,182 | $996,009 |
Shareholders' Equity | |||||
Common Shares | 1,689,452 | 1,778,401 | 1,778,505 | 1,728,356 | 1,617,093 |
Retained earnings | -1,265,536 | -1,270,747 | -1,153,973 | -1,105,551 | -1,076,198 |
Other shareholders' equity | -78,776 | -81,792 | -77,552 | -55,430 | -40,749 |
TOTAL | $428,067 | $425,862 | $546,980 | $567,375 | $587,683 |
Total Liabilities And Equity | $1,358,467 | $1,399,153 | $1,511,231 | $1,550,557 | $1,583,692 |